Tsumura & Co
TSE:4540
Tsumura & Co
Revenue
Tsumura & Co
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Tsumura & Co
TSE:4540
|
Revenue
¥148.8B
|
CAGR 3-Years
8%
|
CAGR 5-Years
5%
|
CAGR 10-Years
3%
|
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
Revenue
¥4.2T
|
CAGR 3-Years
9%
|
CAGR 5-Years
19%
|
CAGR 10-Years
10%
|
|
Daiichi Sankyo Co Ltd
TSE:4568
|
Revenue
¥1.5T
|
CAGR 3-Years
16%
|
CAGR 5-Years
10%
|
CAGR 10-Years
4%
|
|
Otsuka Holdings Co Ltd
TSE:4578
|
Revenue
¥2T
|
CAGR 3-Years
12%
|
CAGR 5-Years
9%
|
CAGR 10-Years
4%
|
|
Chugai Pharmaceutical Co Ltd
TSE:4519
|
Revenue
¥1.1T
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
10%
|
|
Astellas Pharma Inc
TSE:4503
|
Revenue
¥1.9T
|
CAGR 3-Years
15%
|
CAGR 5-Years
8%
|
CAGR 10-Years
6%
|
See Also
What is Tsumura & Co's Revenue?
Revenue
148.8B
JPY
Based on the financial report for Dec 31, 2023, Tsumura & Co's Revenue amounts to 148.8B JPY.
What is Tsumura & Co's Revenue growth rate?
Revenue CAGR 10Y
3%
Over the last year, the Revenue growth was 8%. The average annual Revenue growth rates for Tsumura & Co have been 8% over the past three years , 5% over the past five years , and 3% over the past ten years .